Vanguard Group Inc Kodiak Sciences Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,685,129 shares of KOD stock, worth $15.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,685,129
Previous 1,655,439
1.79%
Holding current value
$15.6 Million
Previous $3.89 Million
13.06%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding KOD
# of Institutions
98Shares Held
39MCall Options Held
6.5KPut Options Held
5.8K-
Baker Bros. Advisors LP New York, NY17.3MShares$160 Million0.48% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$35.6 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.95MShares$18.1 Million0.02% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.02MShares$9.41 Million0.06% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.01MShares$9.33 Million0.34% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $481M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...